entertainment -WSS

entertainment

author：hotspot 2025-10-01 00:58:53 - browse：531

Five elderly people have been blinded in one eye by a severe side effect after receiving injections of a newly approved treatment for eye disease from Apellis Pharmaceuticals. The frequency of this side effect — a severe type of eye inflammation — is low but its cause remains unknown.

The new safety information related to the Apellis drug, called Syfovre, was presented Saturday by a committee of eye disease experts at the annual meeting of the American Society of Retinal Specialists (ASRS).

Apellis cooperated with the ASRS analysis but the company also announced its own internal review Saturday that found fewer cases of retinal occlusive vasculitis, a type of severe eye inflammation that blocks blood flow to the retina and can result in blindness. The rate of retinal occlusive vasculitis reported remains “very rare,” the company said, adding that there is no evidence linking the drug product or its manufacturing to the severe side effect.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Cano Health’s bankruptcy is a warning for Medicare Advantage

hotspot

WSS

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Readout LOUD: Venture capital, Gilead, and more M&A

Class action alleges UnitedHealth concealed DOJ probe

AI for drug discovery: Experts on separating hype from reality

Empower primary care with adequate payments and technology

Why Novartis is going to walk from its acquisition of MorphoSys

focus

entertainment

leisure time

Psychedelics group wrestles with new pharma identity

HHS's proposed rule does nothing to address the climate crisis

DIEP, the 'gold standard' of breast reconstruction, is under threat

Most antidepressants don't work on kids, teens, study finds

The high cost of giving birth even with insurance

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Medical records are filled with copy

Why Novartis is going to walk from its acquisition of MorphoSys

What does generative AI mean for health care? We asked experts

How a small hospital in rural Puerto Rico survived Hurricane Maria

Wikipedia

Why Novartis is going to walk from its acquisition of MorphoSys

Problems with a popular proposal to regulate AI in health care

Updated Covid vaccine has 54% effectiveness, new study suggests

AltruBio raises $225 million to develop ulcerative colitis drug

Most antidepressants don't work on kids, teens, study finds

Readout LOUD: Venture capital, Gilead, and more M&A

hotspot

Wikipedia

knowledge

leisure time